Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 16.00
-0.34 (-2.08%)
Feb 20, 2026, 5:31 PM CET
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 227.56 million as of February 20, 2026. Its market cap has increased by 10.88% in one year.
Market Cap
227.56M
Enterprise Value
250.38M
Revenue
49.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.00
Market Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 227.56M, a decrease of -36.31%. That is a compound annual growth rate of -2.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 227.56M | 35.09% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.02B |
| Basilea Pharmaceutica AG | 663.56M |
| Newron Pharmaceuticals | 420.31M |
| BioVersys AG | 136.84M |
| Molecular Partners AG | 135.38M |
| Xlife Sciences AG | 117.66M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.67M |